Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61.7M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
58M
-
Shares change
-
+1.88M
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$10.4M
-
Put/Call ratio
-
0.42
-
Number of buys
-
89
-
Number of sells
-
-73
-
Price
-
$18.12
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q2 2023
188 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q2 2023.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58M shares
of 61.7M outstanding shares and own 94.06% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.41M shares), FMR LLC (4.24M shares), Deep Track Capital, LP (4.05M shares), Laurion Capital Management LP (3.16M shares), CHI Advisors LLC (3.12M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.97M shares), VANGUARD GROUP INC (2.78M shares), Redmile Group, LLC (2.68M shares), TRV GP IV, LLC (2.13M shares), and First Light Asset Management, LLC (1.81M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.